Harpoon Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 25, 2017
- Vertical
- Immuno-oncology
- Funding URL
- View Funding Page
- Funding Amount:
- $45,000,000
Company Info
- Founders
- Patrick Baeuerle, PhD
- Company Description
- Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.
- Market
- Cancer treatment
- Location
- South San Francisco, California, USA
- Coinvestors
- Arix Bioscience, MPM Capital, New Leaf Venture Partners, Taiho Ventures